ACA entered into an agreement with Walgreens Co. to establish a Pilot Program for AngioScreen® in over 40 Walgreens stores in the Nashville area.

Walgreens has characterized the Pilot Program as a highly successful, preventive health initiative based on store traffic and customer exit interview feedback. A total of 2,901 individuals, or an average of 24 per day, had AngioScreens® performed throughout a 20-week period. Average weekly screenings increased to 163, with screenings running as high as 55 in a single day.

The data extrapolated from the Pilot Program confirms and underscores the significant importance of ACA's mission to inform consumers with increased knowledge and awareness of their risk for heart disease and stroke.

In summary, the Walgreens Pilot Program identified:

  • 62% were overweight or obese based on their Weight, Height, and Body Mass Index. These individuals were at elevated risk for diabetes, heart attack and stroke.
  • 28% indicated the presence of carotid artery plaque, a leading indicator of the risk for heart disease and stroke. 15% of all strokes are caused by plaque build-up in the carotid artery.
  • 20% indicated blood pressure levels consistent with Stage 1 or Stage 2 Hypertension. Americans with uncontrolled high blood pressure and three times more likely to have a heart attack and seven times more like to have a stroke.
  • 4.4% indicated Peripheral Artery Disease. Americans with blockages in their leg arteries are 2 to 4 times more likely thave a heart attack than the general population. More than 10 million Americans have PAD, and 90% are unaware of their condition.
  • 2.2% indicated Atrial Fibrillation, a rapid and irregular heart beat. More than 10 million Americans have A Fib, a serious condition which significantly increases the risk of heart attack or stroke.

6 Months Post Screening Impact